Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.

PubWeight™: 2.07‹?› | Rank: Top 2%

🔗 View Article (PMID 8443755)

Published in Cancer on March 15, 1993

Authors

P M Mauch1, L A Kalish, M Kadin, C N Coleman, R Osteen, S Hellman

Author Affiliations

1: Joint Center for Radiation Therapy, Brigham and Women's Hospital, Boston, MA 02115.

Articles citing this

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med (2003) 6.06

Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys (2005) 1.03

Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theor Biol Med Model (2011) 1.01

Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiat Environ Biophys (2007) 0.95

Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br J Cancer (1999) 0.90

Before it crumbles: Fulminant Hepatic Failure secondary to Hodgkin's Lymphoma. J Community Hosp Intern Med Perspect (2014) 0.79

Hodgkin's lymphoma coexisting with liver failure secondary to acute on chronic hepatitis B. World J Clin Cases (2013) 0.78

Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases. Medicine (Baltimore) (2015) 0.77

Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma. World J Gastroenterol (2010) 0.77

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma. Haematologica (2014) 0.75

Paraspinal mass as a presentation in relapsed Hodgkin lymphoma. South Asian J Cancer (2013) 0.75

Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report. J Med Case Rep (2017) 0.75

An unsual case of persistent inguinal swelling - beware immunodeficiency. JRSM Short Rep (2011) 0.75

Patterns of presentation of Hodgkin disease. Cancer (1993) 0.75

Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature. Case Rep Oncol Med (2015) 0.75

Mediastinal lesions across the age spectrum: a clinicopathological comparison between pediatric and adult patients. Oncotarget (2017) 0.75

Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma. Eur J Nucl Med Mol Imaging (2014) 0.75

Articles by these authors

The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology (1998) 12.32

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05

Oligometastases. J Clin Oncol (1995) 4.95

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst (1999) 4.27

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med (2001) 4.26

Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg (1993) 3.80

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71

Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol (2008) 2.64

Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol (1996) 2.56

Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol (1999) 2.48

Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med (1988) 2.26

Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21

Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med (1996) 2.08

Stopping metastases at their source. N Engl J Med (1997) 2.03

A prospective, randomized clinical trial of universal WBC reduction. Transfusion (2002) 1.99

Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95

Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med (1977) 1.93

Hodgkin's disease: evidence for a tumor-associated antigen. N Engl J Med (1971) 1.83

Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78

Pathogenesis of Hodgkin's disease. Lancet (1972) 1.77

Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res (1993) 1.71

Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am (2006) 1.70

Treatment allocation methods in clinical trials: a review. Stat Med (1985) 1.67

Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (1998) 1.66

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene (1999) 1.62

Proliferative capacity of murine hematopoietic stem cells. Proc Natl Acad Sci U S A (1978) 1.62

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Public health oncology: a framework for progress in low- and middle-income countries. Ann Oncol (2012) 1.59

Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59

Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol (1988) 1.56

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55

Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am (2006) 1.54

Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51

Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am (1998) 1.50

Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am (1997) 1.48

Limited surgery and radiotherapy for early breast cancer. N Engl J Med (1985) 1.48

Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood (1989) 1.45

Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res (1994) 1.44

It's too soon to know. J Natl Cancer Inst (1990) 1.42

Prognostic factors for patients with Hodgkin disease in first relapse. Cancer (1993) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41

Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr (1996) 1.41

Effects of noise and noise suppression on speech perception by cochlear implant users. Ear Hear (1992) 1.40

Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol (1990) 1.39

The key and the lamppost. J Clin Oncol (1999) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Advances in radiation oncology. Lancet (1997) 1.39

The benefits of mammography are not limited to women of ages older than 50 years. Cancer (1998) 1.39

Functional hyposplenia after splenic irradiation for Hodgkin's disease. Ann Intern Med (1982) 1.38

Molecular Biology to Radiation Oncology: A Model for Translational Research? Opportunities in basic and translational research. From a workshop sponsored by the National Cancer Institute, Radiation Research Program, January 26-28, 1997, Bethesda, Maryland. Radiat Res (1998) 1.38

Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. Proc Natl Acad Sci U S A (1980) 1.38

A piece of my mind. Tales of the unnatural: return from the dean(d) JAMA (1998) 1.38

Research in medical physics. Int J Radiat Oncol Biol Phys (2001) 1.37

Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg (1989) 1.37

Oxidative injury rapidly activates the heat shock transcription factor but fails to increase levels of heat shock proteins. Cancer Res (1993) 1.36

The first century of cancer chemotherapy. J Clin Oncol (1998) 1.35

The clinical pharmacology of antineoplastic agents (first of two parts). N Engl J Med (1975) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery (1989) 1.34

'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses. AIDS (2000) 1.33

Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science (1988) 1.32

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Radiation therapy as initial treatment for early stage cancer of the breast without mastectomy. Cancer (1977) 1.29

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol (1997) 1.27

Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells (1979) 1.26

Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood (1991) 1.25

Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol (1997) 1.24

The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS (1999) 1.22

The impact of treatment allocation procedures on nominal significance levels and bias. Control Clin Trials (1987) 1.22

Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation (1988) 1.21

Immunopathology of cutaneous T-cell lymphomas. Am J Pathol (1985) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg (1993) 1.19

Studies of antigens associated with Hodgkin's disease. Blood (1972) 1.18

A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer (1985) 1.16

Purification and properties of cytidine deaminase from normal and leukemic granulocytes. J Clin Invest (1974) 1.16

Treatment of carcinoma of the breast by radiation therapy. Cancer (1977) 1.15

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res (1998) 1.13

Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol (1985) 1.13

The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res (1972) 1.12

Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys (1996) 1.11

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst (1996) 1.11

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol (1995) 1.09

Results of treating stage III carcinoma of the breast by primary radiation therapy. Cancer (1979) 1.09

Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis (1998) 1.07

Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood (1988) 1.07

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. Urology (2001) 1.07

Treatment of lymphoblastic lymphoma in adults. J Clin Oncol (1986) 1.06

Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples. AIDS (2000) 1.06